Scott I. Bearman - Concepedia

Author

Scott I. Bearman

Also Known As

S Bearman, S I Bearman, S. Bearman, S. I. Bearman, S.I. Bearman, SCOTT I. BEARMAN, Scott Bearman, Scott I Bearman, Scott I. Bearman, Scott I. Bearman, MD

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver Fred Hutch Cancer Center University of Colorado Health University of Colorado Boulder University of Washington

About

Scott I. Bearman is an author at University of Colorado Denver specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	2.5K
2	Health Sciences	7	7	1.2K
3	Blood Transplantation	3	3	229
4	Cell Biology	3	3	115
5	Public Health	1	1	264

Scott I. Bearman

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer Robert C. Flanigan, Sydney E. Salmon, Brent A. Blumenstein, New England Journal of Medicine	2001	1.7K
Regimen-related toxicity in patients undergoing bone marrow transplantation. Scott I. Bearman, F R Appelbaum, CD Buckner, Journal of Clinical Oncology Hematological MalignancyTransplantationMarrow TransplantationOncologyBone Marrow Failure	1988	870
Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Keith M. Sullivan, E.D. Agura, Claudio Anasetti, PubMed Other Late ComplicationsGraft-versus-host DiseaseTransplantationMarrow TransplantationStem Cell Transplantation	1991	799
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. Elizabeth J. Shpall, Roy B. Jones, Scott I. Bearman, Journal of Clinical Oncology	1994	393
Transplantation of ex vivo expanded cord blood Elizabeth J. Shpall, Ralph Quinones, Roger Giller, Biology of Blood and Marrow Transplantation	2002	374
MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES Patrick G. Beatty, JOHN A. HANSEN, Gary Longton, Transplantation Unrelated Volunteer DonorsUnrelated DonorsTransplantationOncologyMarrow Transplantation	1991	264
Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. Scott I. Bearman, Garnet L. Anderson, Motomi Mori, Journal of Clinical Oncology	1993	256
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Paul G. Richardson, Anthony Elias, Amrita Krishnan, PubMed	1998	254
Treatment of Hepatic Venocclusive Disease With Recombinant Human Tissue Plasminogen Activator and Heparin in 42 Marrow Transplant Patients Scott I. Bearman, Jung Lim Lee, Anna E. Barón, Blood	1997	189
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer Ian McNiece, Roy B. Jones, Scott I. Bearman, Blood	2000	159

Page 1